CNPAX
Price
$72.71
Change
+$0.65 (+0.90%)
Updated
Jul 31 closing price
Net Assets
170.23B
MLNCX
Price
$26.78
Change
+$0.30 (+1.13%)
Updated
Jul 31 closing price
Net Assets
438.66M
Interact to see
Advertisement

CNPAX vs MLNCX

CNPAX vs MLNCX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MLNCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and MLNCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. MLNCX (439M). CNPAX pays higher dividends than MLNCX: CNPAX (0.97) vs MLNCX (0.00). CNPAX was incepted earlier than MLNCX: CNPAX (24 years) vs MLNCX (10 years). MLNCX (2.08) is less costly to investors than CNPAX (0.74). MLNCX is a more actively managed with annual turnover of: 51.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than MLNCX: CNPAX (250) vs MLNCX (1000). MLNCX annual gain was more profitable for investors over the last year : 7.21 vs. CNPAX (6.66). MLNCX return over 5 years is better than : 44.68 vs. CNPAX (12.85).
CNPAXMLNCXCNPAX / MLNCX
Total Expense Ratio0.742.0836%
Annual Report Gross Expense Ratio0.742.0836%
Fund Existence24 years10 years-
Gain YTD4.9216.14380%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets170B439M38,724%
Annual Yield % from dividends0.970.00-
Returns for 1 year6.667.2192%
Returns for 3 years33.4663.8952%
Returns for 5 years12.8544.6829%
Returns for 10 years113.25163.3869%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIDX0.430.01
+1.53%
20/20 Biolabs Inc
LPTH10.370.05
+0.44%
LightPath Technologies
PROV17.76N/A
N/A
Provident Financial Holdings
RXO20.25-0.32
-1.56%
RXO
MRNA54.82-3.10
-5.35%
Moderna